title: Chemotherapy for diffuse low-grade gliomas in adults.
abstract: Diffuse low-grade gliomas (LGGs) in adults are progressive brain tumours that are radiologically characterized by slow and continuous growth that precedes anaplastic transformation. Standard treatment includes surgery and radiotherapy though the optimal timing of radiotherapy remains unsettled. Several retrospective and phase II studies have demonstrated that chemotherapy is also an interesting treatment option. However, several questions remain unanswered regarding its optimal use. The present review focuses on past, recent and ongoing developments in LGGs chemotherapy, including response assessment and potential predictive biomarkers of chemosensitivity.
authors: INSERM U1028, CNRS UMR5292, service de neuro-oncologie, hôpital neurologique, hospices civils de Lyon, Lyon Neuroscience Research Center, neuro-oncology and neuro-inflammation team, 59 boulevard Pinel, Lyon, France. francois.ducray@chu-lyon.fr
authors: F
authors: F
authors: Ducray
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D059248:Chemoradiotherapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D018450:Disease Progression; D005910:Glioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008130:Lomustine; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011344:Procarbazine; D014750:Vincristine
chemical_list: D011344:Procarbazine; D014750:Vincristine; D008130:Lomustine